These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6163105)

  • 1. Disposition and pharmacological effects of m-Chlorophenylpiperazine in rats.
    Fuller RW; Snoddy HD; Mason NR; Owen JE
    Neuropharmacology; 1981 Feb; 20(2):155-62. PubMed ID: 6163105
    [No Abstract]   [Full Text] [Related]  

  • 2. Structure-activity relationships in the actions of 1-phenyl-piperazines on brain serotonin receptors.
    Fuller RW; Mason NR
    Adv Exp Med Biol; 1981; 133():359-68. PubMed ID: 6172017
    [No Abstract]   [Full Text] [Related]  

  • 3. The influence of quipazine on the turnover rate of serotonin.
    Grabowska M; Antkiewicz L; Michaluk J
    Biochem Pharmacol; 1974 Nov; 23(22):3211-2. PubMed ID: 4441411
    [No Abstract]   [Full Text] [Related]  

  • 4. Substituted piperazines as central serotonin agonists: comparative specificity of the postsynaptic actions of quipazine and m-trifluoromethylphenylpiperazine.
    Fuller RW; Snoddy HD; Mason NR; Hemrick-Luecke SK; Clemens JA
    J Pharmacol Exp Ther; 1981 Sep; 218(3):636-41. PubMed ID: 6167711
    [No Abstract]   [Full Text] [Related]  

  • 5. Neurochemical effects of ET 495 : mechanism of action.
    Hiremagalur J; Keshavan H; Gurbani NK; Dandiya PC
    Pharmacol Res Commun; 1981 Jun; 13(6):607-15. PubMed ID: 6170078
    [No Abstract]   [Full Text] [Related]  

  • 6. Brain serotonin metabolism after tolerance dosage of LSD.
    Freedman DX; Boggan WO
    Adv Biochem Psychopharmacol; 1974; 10():151-7. PubMed ID: 4846536
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of altered brain 5-hydroxytryptaminergic activity on brain tryptophan, 5-hydroxytryptamine and 5-hydroxyindoleacetic acid.
    Marsden CA; Curzon G
    Neuropharmacology; 1976 Nov; 15(11):703-8. PubMed ID: 1004692
    [No Abstract]   [Full Text] [Related]  

  • 8. 1-(1-Naphthyl)piperazine, a central serotonin agonist.
    Fuller RW; Mason NR; Snoddy HD; Perry KW
    Res Commun Chem Pathol Pharmacol; 1986 Jan; 51(1):37-45. PubMed ID: 2419952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the biochemical and behavioural effects of oral nicotine.
    Balfour DJ
    Arch Int Pharmacodyn Ther; 1980 May; 245(1):95-103. PubMed ID: 6157372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors modulating brain serotonin turnover.
    Diaz PM; Ngai SH; Costa E
    Adv Pharmacol (1962); 1968; 6(Pt B):75-92. PubMed ID: 5658336
    [No Abstract]   [Full Text] [Related]  

  • 11. Persistent effects of repeated injections of D-lysergic acid diethylamide on rat brain 5-hydroxytryptamine and 5-hydroxyindoleacetic acid levels.
    Peters DA; Tang S
    Biochem Pharmacol; 1977 Jun; 26(11):1085-6. PubMed ID: 880261
    [No Abstract]   [Full Text] [Related]  

  • 12. Reversal learning enhanced by lysergic acid diethylamide (LSD): concomitant rise in brain 5-hydroxytryptamine levels.
    King AR; Martin IL; Melville KA
    Br J Pharmacol; 1974 Nov; 52(3):419-26. PubMed ID: 4458849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of morpholino-, pyrrolidino-, piperizino-, and cyclo-octyl-derivatives of beta-alanine on brain amines and amino acids.
    Leonard BE; Liska KJ
    Life Sci I; 1971 Jan; 10(2):93-104. PubMed ID: 5575407
    [No Abstract]   [Full Text] [Related]  

  • 14. Lisuride- and D-LSD-induced changes of monoamine turnover in the rat brain.
    Keller HH; Burkard WP; Pieri L; Bonetti EP; Da Prada M
    Adv Biochem Psychopharmacol; 1978; 19():393-6. PubMed ID: 696467
    [No Abstract]   [Full Text] [Related]  

  • 15. Differential neuroendocrine responses to the 5-HT agonist m-chlorophenylpiperazine in Fawn-Hooded rats relative to Wistar and Sprague-Dawley rats.
    Aulakh CS; Wozniak KM; Hill JL; Devane CL; Tolliver TJ; Murphy DL
    Neuroendocrinology; 1988 Oct; 48(4):401-6. PubMed ID: 2463494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of lysergic acid diethylamide on the metabolism of brain 5-hydroxytryptamine.
    Rosecrans JA; Lovell RA; Freedman DX
    Biochem Pharmacol; 1967 Oct; 16(10):2011-21. PubMed ID: 6065966
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of brain 5-hydroxytryptamine in the central action of L-DOPA.
    Maj J; Pawlowski L; Sarnek J
    Adv Biochem Psychopharmacol; 1974; 10():253-6. PubMed ID: 4846541
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative effects of p-chloroamphetamine and 1-(p-chlorophenyl)piperazine on 5-hydroxyindole concentration in rat brain.
    Fuller RW; Snoddy HD
    Res Commun Chem Pathol Pharmacol; 1980 Jul; 29(1):201-4. PubMed ID: 6157183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The actions of neuroleptic drugs and putative serotonin receptor antagonists on LSD and quipazine-induced reductions of brain 5-HIAA concentrations.
    Jacoby JH; Poulakos JJ
    J Pharm Pharmacol; 1977 Dec; 29(12):771-3. PubMed ID: 22629
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on the concurrent behavioral and neurochemical effects of psychoactive drugs using the push-pull cannula.
    Tilson HA; Sparber SB
    J Pharmacol Exp Ther; 1972 Jun; 181(3):387-98. PubMed ID: 5033008
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.